JPWO2021168128A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021168128A5 JPWO2021168128A5 JP2022549518A JP2022549518A JPWO2021168128A5 JP WO2021168128 A5 JPWO2021168128 A5 JP WO2021168128A5 JP 2022549518 A JP2022549518 A JP 2022549518A JP 2022549518 A JP2022549518 A JP 2022549518A JP WO2021168128 A5 JPWO2021168128 A5 JP WO2021168128A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- transplant
- less
- antibody
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062978141P | 2020-02-18 | 2020-02-18 | |
| US62/978,141 | 2020-02-18 | ||
| US202063062845P | 2020-08-07 | 2020-08-07 | |
| US63/062,845 | 2020-08-07 | ||
| PCT/US2021/018599 WO2021168128A1 (en) | 2020-02-18 | 2021-02-18 | Compositions and methods for allogeneic transplantation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023514347A JP2023514347A (ja) | 2023-04-05 |
| JPWO2021168128A5 true JPWO2021168128A5 (https=) | 2024-02-26 |
| JP2023514347A5 JP2023514347A5 (https=) | 2024-02-26 |
Family
ID=77391794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549518A Pending JP2023514347A (ja) | 2020-02-18 | 2021-02-18 | 同種移植のための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230390412A1 (https=) |
| EP (1) | EP4107188A4 (https=) |
| JP (1) | JP2023514347A (https=) |
| KR (1) | KR20220154676A (https=) |
| CN (1) | CN115397444A (https=) |
| AU (1) | AU2021224663A1 (https=) |
| CA (1) | CA3168039A1 (https=) |
| IL (1) | IL295653A (https=) |
| MX (1) | MX2022009885A (https=) |
| WO (1) | WO2021168128A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4051711A4 (en) * | 2019-11-01 | 2024-02-21 | Magenta Therapeutics, Inc. | ANTI-CD45 ANTIBODIES AND THEIR CONJUGATES |
| US12496303B2 (en) * | 2020-10-19 | 2025-12-16 | Washington University | Conditioning agents for use in allogeneic hematopoietic stem cell transplantation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3174902B1 (en) * | 2014-08-01 | 2019-04-17 | Institut National de la Sante et de la Recherche Medicale (INSERM) | An anti-cd45rc antibody for use as drug |
| HK1249534A1 (zh) * | 2015-04-06 | 2018-11-02 | 哈佛大学校长及研究员协会 | 用於非清髓性预处理的组合物和方法 |
| CN109641051A (zh) * | 2016-06-17 | 2019-04-16 | 美真达治疗公司 | 用于耗尽细胞的组合物和方法 |
| EP3595683A1 (en) * | 2017-03-15 | 2020-01-22 | Orca Biosystems, Inc. | Compositions and methods for hematopoietic stem cell transplants |
-
2021
- 2021-02-18 CA CA3168039A patent/CA3168039A1/en active Pending
- 2021-02-18 MX MX2022009885A patent/MX2022009885A/es unknown
- 2021-02-18 JP JP2022549518A patent/JP2023514347A/ja active Pending
- 2021-02-18 IL IL295653A patent/IL295653A/en unknown
- 2021-02-18 EP EP21756915.1A patent/EP4107188A4/en active Pending
- 2021-02-18 CN CN202180027333.1A patent/CN115397444A/zh active Pending
- 2021-02-18 KR KR1020227028992A patent/KR20220154676A/ko active Pending
- 2021-02-18 WO PCT/US2021/018599 patent/WO2021168128A1/en not_active Ceased
- 2021-02-18 AU AU2021224663A patent/AU2021224663A1/en active Pending
-
2022
- 2022-08-17 US US17/820,540 patent/US20230390412A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6018622B2 (ja) | Ｃｄ３７結合性分子及びその免疫複合体 | |
| McSweeney et al. | Mixed chimerism: preclinical studies and clinical applications | |
| Lazarus et al. | Prevention and treatment of acute graft-versus-host disease: The old and the new. A report from the Eastern Cooperative Oncology Group (ECOG). | |
| US5635156A (en) | Non-lethal methods for conditioning a recipient for bone marrow transplantation | |
| CN102271711B (zh) | 每种维持移植物抗肿瘤效应的免疫重建促进剂或感染预防剂 | |
| EP2490715A1 (en) | Novel dosing regimen and method of treatment | |
| WO2020081910A1 (en) | Near infrared photoimmunotherapy | |
| CN118356508A (zh) | 使用抗体-药物缀合物调节免疫应答 | |
| US20190000969A1 (en) | Novel anti-upk1b antibodies and methods of use | |
| CN117157098A (zh) | 一种药物组合及其用途 | |
| JP2019525727A (ja) | 新規の抗ｔｎｆｒｓｆ２１抗体及び使用方法 | |
| Jacobsohn | Novel therapeutics for the treatment of graft-versus-host disease | |
| Blazar et al. | Prevention of murine graft-versus-host disease and bone marrow alloengraftment across the major histocompatibility barrier after donor graft preincubation with anti-LFA1 immunotoxin | |
| JPWO2021168128A5 (https=) | ||
| CZ161288A3 (en) | Immunoglobulin conjugate, process of its preparation and pharmaceutical composition containing thereof | |
| Waldmann | The multichain interleukin 2 receptor: A target for immunotherapy in lymphoma, autoimmune disorders, and organ allografts | |
| Sandmaier et al. | Nonmyeloablative therapy and hematopoietic cell transplantation for hematologic disorders | |
| CN114173820A (zh) | 用于治疗自身免疫疾病的方法和组合物 | |
| ES2286006T3 (es) | Prevencion del rechazo cronico a transplante mediante combinacion de inmunotoxinas y bloqueadores de la coestimulacion. | |
| US20060051355A1 (en) | Methods and means for the treatment of immune-related diseases | |
| US20220347313A1 (en) | Combination Anti-CD30 ADC, Anti-PD-1 and Chemotherapeutic for Treatment of Hematopoietic Cancers | |
| ES2213355T3 (es) | Cocteles de inmunotoxinas para el tratamiento de enfermedades de origen inmunologico. | |
| Routledge | Belantamab mafodotin. Antibody-drug conjugate targeting B-cell maturation antigen (BCMA), Treatment of multiple myeloma | |
| WO1998056823A1 (en) | Induction of immune tolerance by immunotoxin | |
| CN120359242A (zh) | 靶向cd117和cd3的双特异性抗体 |